174 related articles for article (PubMed ID: 28286738)
21. Regulation of mTORC1 by PI3K signaling.
Dibble CC; Cantley LC
Trends Cell Biol; 2015 Sep; 25(9):545-55. PubMed ID: 26159692
[TBL] [Abstract][Full Text] [Related]
22. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
Allard EK; Grujic M; Fisone G; Kristensson K
Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760
[TBL] [Abstract][Full Text] [Related]
23. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.
Taneike M; Nishida K; Omiya S; Zarrinpashneh E; Misaka T; Kitazume-Taneike R; Austin R; Takaoka M; Yamaguchi O; Gambello MJ; Shah AM; Otsu K
PLoS One; 2016; 11(3):e0152628. PubMed ID: 27023784
[TBL] [Abstract][Full Text] [Related]
24. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
25. Vasopressin activates Akt/mTOR pathway in smooth muscle cells cultured in high glucose concentration.
Montes DK; Brenet M; Muñoz VC; Burgos PV; Villanueva CI; Figueroa CD; González CB
Biochem Biophys Res Commun; 2013 Nov; 441(4):923-8. PubMed ID: 24216105
[TBL] [Abstract][Full Text] [Related]
26. mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.
Komatsu N; Fujita Y; Matsuda M; Aoki K
Oncogene; 2015 Nov; 34(45):5607-16. PubMed ID: 25703330
[TBL] [Abstract][Full Text] [Related]
27. The rapid activation of protein synthesis by growth hormone requires signaling through mTOR.
Hayashi AA; Proud CG
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1647-55. PubMed ID: 17284572
[TBL] [Abstract][Full Text] [Related]
28. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
29. PMA induces GCMa phosphorylation and alters its stability via the PKC- and ERK-dependent pathway.
Yasui Y; Yamada K; Takahashi S; Sugiura-Ogasawara M; Sato K; Miyazawa D; Sugiyama T; Kitade Y; Ueda H
Biochem Biophys Res Commun; 2012 Jan; 417(4):1127-32. PubMed ID: 22206674
[TBL] [Abstract][Full Text] [Related]
30. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
31. Glycine Regulates Protein Turnover by Activating Protein Kinase B/Mammalian Target of Rapamycin and by Inhibiting MuRF1 and Atrogin-1 Gene Expression in C2C12 Myoblasts.
Sun K; Wu Z; Ji Y; Wu G
J Nutr; 2016 Dec; 146(12):2461-2467. PubMed ID: 27798331
[TBL] [Abstract][Full Text] [Related]
32. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
Ma L; Teruya-Feldstein J; Bonner P; Bernardi R; Franz DN; Witte D; Cordon-Cardo C; Pandolfi PP
Cancer Res; 2007 Aug; 67(15):7106-12. PubMed ID: 17671177
[TBL] [Abstract][Full Text] [Related]
33. Measurements of TSC2 GAP activity toward Rheb.
Li Y; Inoki K; Vikis H; Guan KL
Methods Enzymol; 2006; 407():46-54. PubMed ID: 16757313
[TBL] [Abstract][Full Text] [Related]
34. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts.
Sarbassov DD; Jones LG; Peterson CA
Mol Endocrinol; 1997 Dec; 11(13):2038-47. PubMed ID: 9415407
[TBL] [Abstract][Full Text] [Related]
35. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
[TBL] [Abstract][Full Text] [Related]
36. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
37. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic KRAS signaling activates mTORC1 through COUP-TFII-mediated lactate production.
Byun JK; Park M; Yun JW; Lee J; Kim JS; Cho SJ; Lee YM; Lee IK; Choi YK; Park KG
EMBO Rep; 2019 Jun; 20(6):. PubMed ID: 30988000
[TBL] [Abstract][Full Text] [Related]
39. Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes.
Wang Y; Huang BP; Luciani DS; Wang X; Johnson JD; Proud CG
J Mol Cell Cardiol; 2008 Dec; 45(6):812-20. PubMed ID: 18722381
[TBL] [Abstract][Full Text] [Related]
40. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
